Device Makers Want More Protections For Collecting Off-Label Data
This article was originally published in The Gray Sheet
Executive Summary
Government agencies should create a safe harbor where industry can collect post-market clinical data without fear of being perceived as promoting off-label use, industry speakers said at the Transcatheter Cardiovascular Therapeutics conference in San Francisco last month